immunotherapy
Immune checkpoint inhibitors (ICIs), such as anti-PD-1 and anti-PD-L1 antibodies, are cancer immunotherapies that release brakes on T cell antitumor activity.
Related terms
Source papers
- Exercise-Induced Microbiota Metabolite Enhances CD8 T Cell Antitumor Immunity Promoting Immunotherapy Efficacy doi:10.1016/j.cell.2025.06.018